VECTURA GROUP (VEC.L, LSE, LSE:VEC)

VEC Share PerformanceMore

52 week high171.50 19/02/14
52 week low103.00 26/11/13
52 week change 28.75 (27.32%)
4 week volume27,384,545 30/10/14

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Vectura granted approval for inhaler

Vectura Group has confirmed that its partner, Sandoz, has been granted marketing authorisation by the regulatory autho...

Czech and Irish Approval for AirFluSal Forspiro

Miscellaneous medium priority announcements

Vectura upgraded by Investec

Investec has upgraded its recommendation on respiratory disease treatment specialist Vectura (LON:VEC) to buy from ho...

Vectura appoints CFO, widens H1 pretax loss

Vectura has widened its H1 pretax loss to 7.1m, from a year-earlier loss of 1.2m. Revenue was 19.4m, from 17.0m. Separately, ...

Appoints Andrew Oakley as Group CFO

Notification of any change to a company’s board e.g. appointments/resignations/changes to important functions or executive responsibilities of a director

Half Yearly Report

Announcement of half-year/second quarter financial results

Vectura triggers further milestone for VR315

Vectura Group confirms it has triggered a further milestone associated with the development of VR315 in the US. VR315 is...

VR315 US development milestone

Miscellaneous medium priority announcements